It has become clear that the IL-33/ST2 signaling pathway facilitates glioma cell proliferation and migration, as treatment of the cells with IL-33 shRNA or ST2 shRNA reduces cell growth and colony formation in culture and reduces tumor volume in vivo (102). This evidence concerns the gene IL1RL1 and glioma.